TwentyTwentyTweetsTweets by 2020health
Join 7,195 other subscribers
Category Archives: Election
Guest Blogspot: Think carefully about value-based drug pricing in the UK and let common sense prevail.
David Cameron and Jeremy Hunt share an important skill. They both have firsts from Oxford in Politics, Philosophy and Economics (PPE). I am not the greatest fan of this course because I would like to see more scientists, engineers and … Continue reading
Posted in Business, competition, David Cameron, Department of Health, Drugs, Election, Jeremy Hunt, NHS, Patients, Pharma, Policy, Primary Care Tagged 2020health, block-buster, competition, David Cameron, demand, Department of Health, drug pricing system, Drugs, elderly, GP, GPs, Health Bill, innovation, medicine, National Health Service, NHS, NICE, parallel exports, parallel imports, patient, Patients, pharmaceutical, Philosophy and Economics, Politics, PPE, PPRS, pricing, quality of life, R&D, reference price, Research, value-based, value-based pricing, VBP Leave a comment
Guest Blogspot: A wrong decision on UK drug pricing could seriously undermine all the good work that HM Treasury and the Department for Business, Innovation and Skills have done to encourage the UK pharmaceutical industry.
The recent local elections highlight the political dangers ahead. The current UK coalition government has lost popularity through decisions that do not all relate to austerity measures. Shortly after the General Election Andrew Lansley’s plans to increase the say of … Continue reading
Posted in Andrew Lansley, Business, Department of Health, Drugs, Election, Global Health, Health Bill, NHS, Patient choice, Patients, Pharma, Policy, Research, Technology Tagged 2020health, Andrew Lansley, AstraZeneca, Department of Health, Drugs, GlaxoSmithKline, GSK, health, Health Bill, innovation, medicine, National Health Service, NHS, NICE, patient, Patients, pharmaceutical, PPRS, pricing, R&D, Research, value-based, value-based pricing Leave a comment
Political Mood Change over the NHS, Innovation and the Pharmaceutical Industry in 2011
As 2011 draws to a close now is a good time to reflect on the period since the last UK General Election in 2010. We must consider what we have done right, what we have done wrong and what remains … Continue reading
Posted in Business, David Cameron, Department of Health, Drugs, Election, Genetics, Health Bill, Health Team, Hospitals, Innovation, NHS, Pharma, Policy, Research Tagged 2020health, David Cameron, Department of Health, Drugs, genetics, government, GPs, Health Bill, innovation, medicine, National Health Service, NHS, NICE, Pfizer, pharmaceutical, PPRS, pricing, R&D, Research, value-based, value-based pricing Leave a comment
NHS Reforms- The waiting room
The King’s Fund has recently published a report that has revealed that waiting room times have increased since June 2010. The Guardian, reporting on this, comments that most of the arguments put forward for NHS reform become irrelevant when the … Continue reading
Posted in competition, David Cameron, Department of Health, Election, Finance, Health Bill, Hospitals, NHS, Policy, Private Tagged David Cameron, Health Bill, NHS, patient, Responsibility in healthcare Leave a comment
Health Team with experience bodes well
Well it’s slow going but so far we know that Paul Burstow, Simon Burns and Anne Milton are in Andrew Lansley’s new team. They all come with a track record of involvement with health which will mean they can all … Continue reading
Posted in Andrew Lansley, Election Tagged Anne Milton, Paul Burstow, Simon Burns Leave a comment
What will a ConLib partnership do for health?
Well according to our policy tracker there is more common ground between the Tories and the Lib Dems than you might think. The big differences are that the Tories would want an Independent NHS Board, thousands more health visitors and … Continue reading
Posted in Election Tagged election, NHS, reorganisation Leave a comment
Kings Fund withdrawal of accusation of ‘sleight of hand’ & DH still tweeting
Yesterday 2020health blogged on the King’s Fund accusation of dishonesty of claims that the Conservative Party could fund more cancer drugs by savings made from a rise in National Insurance. This accusation, as we pointed out yesterday, is factually incorrect … Continue reading
Posted in Department of Health, Election Leave a comment
You must be logged in to post a comment.